[This review was originally posted at the Nieman Journalism Lab Synthroid Price, on June 11, 2010.]
The Times has the Pulse (briefly) pulled: Last week, I noted one of the more interesting iPad news apps: The Pulse Reader, designed by two Stanford grad students, is a stylish news aggregator. But on Monday, the app was pulled from the iTunes store based on a claim that it infringes on The New York Times' copyright after some Times folks saw the paper's own blog post about the reader. The app was reinstated the next day, but the debate over copyright, aggregation and mobile apps had already taken off.
The central point of the Times' argument was that the $3.99 app was an illegal attempt to make money off of the Times' (and the Boston Globe's) free, publicly available RSS feeds, rx free Synthroid. (The paper also objected to app's placement of the Times' content within a frame on the iPad.) The Citizen Media Law Project's Kimberley Isbell helpfully broke down the Times' claims and the Pulse Reader's possible fair-use defenses, noting the Times articles' free accessibility and the relatively small article portions displayed on the reader.
Reaction on the web weighed overwhelmingly against the Times: Wired contended that every piece of paid software used to access the Times' site would be outlawed by the paper's logic, while Techdirt's Mike Masnick argued that Pulse was selling its software, not the Times' feeds, Synthroid Price. GigaOm's Mathew Ingram wondered whether the Times was declaring war on news aggregators, and the Sydney Morning Herald reasoned that if the Times is offering its RSS for free, it can't complain when someone designs a reader to view it. Blogging and RSS vet Dave Winer had the harshest response in a post arguing that the Times is in the business of news production, Fast shipping Synthroid, not distribution: "Look, if the Times is depending on stopping those two kids for its future, then the Times has no future."
The reader's creators were just as baffled as anybody about why the app was reinstated, a Times' spokesman apparently tried to pass off the complaint as a mistake, though that response doesn't exactly square with the Times' Martin Nisenholtz's reiteration of the paper's case to paidContent's Staci Kramer. As for whether this claim would apply beyond the Pulse Reader, Nisenholtz said it would be handled "on a case by case basis."
We had plenty of other iPad news this week, too — Jobs made a number of mostly iPhone-related announcements at a conference on Monday, Synthroid recreational, and the Lab's Josh Benton explained what they mean for mobile news. A few highlights: Apple's not too concerned about app-banning controversies, but it is moving decisively on ebooks and its iAd mobile advertising platform. The AP reported that publishers are seeing encouraging early signs Synthroid Price, about wringing advertising dollars out of the iPad, but Ken Doctor went on a wonderful little rant against publishers that are slow to take advantage of the iPad's capabilities. Meanwhile, the Wall Street Journal's Robert Thomson slammed news orgs' repurposed "crapps" and talked, with the Journal's Les Hinton, Buy cheap Synthroid, about his paper's own iPad strategy. And the iPad faced its first major security issue, as the email addresses of its 114,000 owners were exposed by hackers.
The purpose of the link: A Nicholas Carr post last week ignited a spirited discussion about the relative values of the link, and that conversation continued this week with twin Wall Street Journal columns by Carr and web scholar Clay Shirky debating whether the Internet makes us smarter. Carr said no, using a similar argument to the one he laid out in his earlier post (it's also the central point of his new book): The Internet encourages multitasking and bite-size information, making us all "scattered and superficial thinkers."Shirky said yes, Synthroid without prescription, arguing that the Internet enables never-before-experienced publishing and connective capabilities that allow us to put our cognitive surplus to work for a better society. (That's also the central point of his new book.) Quite a few people, led by GigaOm's Mathew Ingram, posited that both writers were right - Carr in the short term, Shirky in the long term.
Here at the Lab, Jason Fry weighed in on the delinkification debate, giving a useful classification of the link's primary purposes — credibility, readability and connectivity, Synthroid Price. Credibility has become a vital function in today's web, Synthroid for sale, Fry said, though he conceded Carr's point that the link adds to the cognitive load when it comes to readability. Based on Carr's original post, the web design firm Arc90 added an option to its browser extension to convert hyperlinks to footnotes.
The Lab also ran a fantastic three-part series on links by Jonathan Stray exploring four journalistic purposes of the hyperlink (it's essential, he says), examining the way news organizations talk about links (they're a bit muddled) and studying how much those news organizations actually link (not a whole lot, especially the wire services), Synthroid trusted pharmacy reviews. It's a tremendously helpful resource for anyone interested in looking at how linking and journalism intersect.
Debate over Newsweek's bidders: We found out about three bidders for Newsweek Synthroid Price, last Thursday, so last Friday was the time for profiles and commentary, much of it centered on the conservative news site and magazine Newsmax. Newsmax's CEO, Christopher Ruddy, told the Washington Post that it has a number of non-conservative media projects, so Newsweek wouldn't have to adopt a conservative viewpoint to be part of Newsmax's plans. "Newsmax's success is in its business model, Synthroid dose, not just its editorial approach," Ruddy said. Newsweek employees were worried about the prospect of a Newsmax-owned Newsweek, but the New York Times' Ross Douthat, himself a conservative, said Newsmax's influence could be just the nudge Newsweek needs to hit its sweet spot in America's heartland. Chicago magazine profiled another bidder, venture capitalist Thane Ritchie, Synthroid pics, while the Washington Post reported that audio equipment exec Sidney Harman is considering a bid, too.
Washington Post media critic Howard Kurtz devoted a column to the publicly acknowledged bidders, exploring the question of why no major players have emerged as bidders and concluding that the lack of interest "amounts to a no-confidence vote not just on the category of newsweeklies, which have long been squeezed between daily papers and in-depth monthlies, but on print journalism itself." Newsweek, via its Tumblr, ripped apart the work of its Washington Post Co, Synthroid Price. colleague, taking to task for a lack of evidence and disputing his claim that the re-envisioned Newsweek is a flop. (That Tumblr is written by Newsweek social-media guru David Coatney, who got a New York Daily Intel Q&A a couple of days later.) Meanwhile, Synthroid natural, New York Times columnist David Carr proposed eight ways to revive Newsweek.
A sports blog network goes local: ESPN has been making a well-documented and initially successful local sports media play over the past year, but this week, a very different sports media company is making a push into what used to be local newspapers' territory. SB Nation, a network of more than 250 fan-run sports blogs founded in 2003 by Tyler Bleszinski and Daily Kos' Markos Moulitsas Zuniga, began rolling out 20 city-specific sports media hubs. Synthroid Price, Until now, the company has focused on team-specific (or sport-specific, in the case of some less prominent sports) blogs, but the new sites will aggregate real-time sports news mixed with fan-generated conversation and commentary.
In a New York Times feature, generic Synthroid, SB Nation's Jim Bankoff said that while his company is trying to provide a ground-up alternative to traditional sports coverage, he'd be happy to collaborate with local newspapers. Former ESPN.com columnist Dan Shanoff echoed that perspective, saying that SB Nation's brand of sharp fan analysis is ripe for media partnerships because "it is something that local newspapers and local cable-sports networks can't or won't do well." Shanoff proposed that SB Nation become a piece of a larger media company's local media strategy, suggesting Comcast as an ideal fit.
Here at the Lab, Is Synthroid addictive, Bankoff gave Laura McGann a handful of lessons media organizations could learn from the SB Nation model, including tightly focused subject matter and maximizing repeat visitors. SB Nation's team-specific focus seems to be a major component in its success, and could have some ready implications for news organizations, as Bankoff noted: “We’re not fans of sports — we’re fans of teams. We’re not fans of television, Synthroid Price. We’re fans of shows.”
Reading roundup: This week, I've got two news items, a few interesting pieces of commentary and one set of tips, purchase Synthroid online no prescription.
— Advertising Age reported that AOL is planning to hire hundreds of journalists for a major expansion into news production. At the local media blog Lost Remote, Cory Bergman, who owns a local news network himself, noted that AOL's hyperlocal outfit Patch is making 300 of those hires and wondered what it will mean for local news.
— Los Angeles Times media writer James Rainey wrote a piece on the Las Vegas Review-Journal, a newspaper that has poured legal resources into stopping people who use its content without permission. The Times' Mark Milian also provided a quick guide Synthroid Price, to what's OK and what's not when reposting.
— Publish2's Scott Karp wrote an intriguing essay on the concept of a Content Graph, in which media organizations collaborate through distribution to enhance their brand's value.
— News business guru Alan Mutter sensed a theme among news startups — too much focus on news, not enough on business — and wrote a stiff wakeup call.
— Two journalism/tech folks, japan, craiglist, ebay, overseas, paypal, Jeff Sonderman and Michelle Minkoff, wrote a bit about what journalism school is — and isn't — good for. Both are worthwhile reads.
— Finally, British journalism David Higgerson has 10 ideas for building good hyperlocal websites. Most of his (very practical) ideas are useful not just for hyperlocal journalism, but for online news in general.
Similar posts: Cipro No Rx. Buy Flagyl No Prescription. Diflucan Over The Counter. Diflucan results. Diflucan alternatives. Doses Zoloft work.
Trackbacks from: Synthroid Price. Synthroid Price. Synthroid Price. Synthroid schedule. Purchase Synthroid for sale. Synthroid results.
[This review was originally posted at the Nieman Journalism Lab Cipro Price, on April 23, 2010.]
Facebook tries to connect the web: Most of the talk on journalism and the web this week was about two tech giants making moves that, for the most part, aren’t making users and commentators happy. The first one I’ll run down is Facebook — its moves this week aren’t as directly tied to journalism as Apple’s, but their scope seems a lot larger. On Wednesday, Purchase Cipro, Facebook unveiled a set of tools that will allow its site to be integrated across the web by remembering users’ preferences and tying them all together through their Facebook accounts. GigaOm’s Liz Gannes and Om Malik have helpful overviews of the individual social features and Facebook’s larger plans.
What this means is that you’re going to be seeing a ton of Facebook around the internet and a ton of data — much of it personal — sent through Facebook’s connections. As tech guru Robert Scoble writes, this appears to be an incredibly ambitious move that could transform the look and feel of the web. Marshall Kirkpatrick of ReadWriteWeb notes that while it’s hard to find fault initially with anything specific about Facebook’s announcement, people are going to justifiably be concerned with the fact that the material Facebook is using to make the web social is formerly private information from its users.
And within the first day of commentary, order Cipro from United States pharmacy, a lot of people were concerned. TechCrunch’s MG Siegler thought Facebook took control of the internet with the move, saying that it’s backing up its assertion that “social connections are going to be just as important going forward as hyperlinks have been for the web.” Liz Gannes said Facebook’s asking for a lot of trust from developers and later pinpointed its “instant personalization” as the main privacy problem, Cipro Price. Both Dave Winer and Robert Scoble marveled at Facebook’s audacity and the niftiness of its API, but both had big concerns about seeing so much power and data given to one company. Ordering Cipro online, Winer summed the position well: “Facebook is to be the identity system for the web. A company. That just can’t work. I can’t believe he doesn’t know that.”
Cipro Price, So what does this mean for news orgs? In a post for ReadWriteWeb, Facebook marketer Chris Treadway took a first stab at an answer. Facebook is making social media (and itself in particular) pervasive across the web, Treadway argues, so it has to be a top consideration when designing, developing and creating content for newspapers. He says newspapers need to hire not just web developers, but Facebook developers. “The decline of those news sources that fail to realize the necessary potential of Facebook will be swift. … It’s becoming a necessary core competency, Cipro used for, and fast.”
On the privacy front, a few people explained exactly which of Facebook’s new features might be problematic: The aforementioned Liz Gannes on "instant personalization"; paidContent’s Joseph Tarkatoff on allowing other sites to hold onto Facebook users’ data; grad student Arnab Nandi on “liking” sites you’ve never visited; and Mashable’s Christina Warren on the Open Graph API. Warren nails the essential change in Facebook privacy: “Public no longer means ‘public on Facebook, Order Cipro no prescription, ’ it means ‘public in the Facebook ecosystem.’”
The iPad’s control over news apps: The other big tech company to draw criticism this week was Apple, for the continued controversy over its control over iPhone and iPad apps. About the time this post went up last Friday, we found out that Apple was reconsidering the iPhone app by Pulitzer-winning cartoonist Mark Fiore, which it initially rejected for mocking public figures, about Cipro. (Here are The New York Times’ and the Lab’s reports of the news.) Later that day, Apple chief Steve Jobs called the rejection a mistake, Cipro Price. And a few days later, Fiore’s app was approved.
Several people used the episode as a window into the larger issue of Apple’s control over apps on the iPhone or iPad. The Columbia Journalism Review’s Ryan Chittum called for all news orgs to remove their apps in protest: The press, Cipro duration, he said, “would never let the government have such power over its right to publish. It shouldn’t let any corporation have it, either.”Media critic Dan Gillmor asked several major news orgs whether Apple has the power to disable their iPad apps and heard nothing back. And CNET’s Erica Ogg wondered if publishers’ embrace of the iPad will give Apple even more of an upper hand.
In other iPad-related bits, real brand Cipro online, a CNET panel of reporters discussed that (seemingly) age-old question of whether it can save newspapers and magazines, and Jennifer McFadden looked at some hard numbers and concluded that the answer is probably no. Cipro Price, Meanwhile, PR exec Steve Rubel took a mostly positive look at three trends the iPad might accelerate.
A search for investigative reporting funding: Cal-Berkeley held its annual Reva and David Logan Investigative Reporting Symposium last weekend, and it touched on some very timely topics as the news ecosystem expands to include more nontraditional sources. Chris O’Brien provided quite a bit of coverage for PBS MediaShift, Discount Cipro, writing detailed summaries of the back-and-forth exchanges on several panels. His day-one post includes discussions of collaboration between news orgs, the consequences of investigative reporting, and funding sources, and his day-two edition covers a panel on new investigative initiatives.
In a post written after the event, order Cipro online overnight delivery no prescription, O’Brien zeroed in on one of those initiatives, WikiLeaks, coming away impressed that the whistle-blowing organization professionally vets its tips and has carefully structured itself to be protected from lawsuits. Low dose Cipro, He also looked more closely at two of the nonprofits talked about in the symposium’s panels, ProPublica and the new Bay Citizen. He remained a bit skeptical about the Bay Citizen but noted its editor’s statement that the nonprofit model is becoming more viable as private capital from investors for journalism — as opposed to aggregation — dries up.
The Lab’s Laura McGann also wrote about the day-one panel on funding sources, focusing on the broad-based, experimental revenue-generating philosophy that one panelist described as “revenue promiscuity.”
NYU prof and web thinker Clay Shirky and veteran journalist Walter Robinson also talked about the future of investigative journalism this week at Harvard, buy Cipro online cod, and the Lab had the audio and transcript. The two talked about the Boston Globe’s work to uncover Boston’s priest abuse scandal, and Laura McGann summarized the reasons they said a small online news org would have a tough time doing the same thing, Cipro Price. The whole thing’s well worth a read/listen if you’re interested in the future of accountability journalism by nontraditional sources.
Reading roundup: We had a ton of interesting pieces this week that didn’t fit very well in a larger item, so I’ll pull them all together into a longer-than-usual reading roundup.
— The Associated Press, Cipro coupon, arbiter of much of American newsrooms’ copy style, announced it was changing “Web site” to “website.” Among journalists who hang out online, the news was mostly met with glee. Poynter’s Mallary Jean Tenore got some reaction, and the Online Journalism Review’s Robert Niles said young journalists need to spend more time learning SEO (search engine optimization) style than AP style.
— A sequel to the “hot news doctrine” case we looked at last month: Dow Jones sued Briefing.com for aggregating and summarizing content from their financial newswire under the same doctrine, Cipro schedule. Here’s the story from Bloomberg, the Citizen Media Law Project and paidContent, which has a copy of the suit.
— Here’s a few cool curated resources you might find helpful: Josh Stearns put together a list of collaborations between news outlets, Cipro australia, uk, us, usa, Columbia j-prof Sree Sreenivasan compiled social media tips for journalists (Kaukab Jhumra Smith has a shorter version), and USC j-prof David Westphal has a comprehensive list of public policy and funding ideas for journalism.
— Two interesting future-of-journalism case studies: One by Cindy Royal of Texas State-San Marcos on The New York Times interactive news technology department, and the other by J-Lab’s Jan Schaffer on the Philadelphia news ecosystem.
— Salon vet and blogging historian Scott Rosenberg launched MediaBugs, an open-source service that tracks media errors with the aim of correcting them more quickly and reliably. Poynter and the Lab both have write-ups.
— News business analyst Alan Mutter provides a critique of several of the most popular online paid-content models right now, then concludes that “it won’t matter what pay model publishers choose, unless they produce unique and compelling content, tools or applications that readers can’t find anywhere else.”
— Finally, two neat ideas to give some thought: Open-government activist David Eaves ably dissects five old-media myths about journalism and new media, and the Lab’s Megan Garber goes through the attributes that writer Dave Eggers associates with print, pointing out that those principles could apply just as well to the web. “They offer insights into what many consumers want out of news in general, regardless of platform,” she writes, as well as “a challenge to (and, more optimistically, a vision for) news organizations and web designers alike.”.
Similar posts: Armour No Rx. Tramadol Dosage. Cephalexin For Sale. After Synthroid. Buy Bactrim from canada. Cheap Cipro.
Trackbacks from: Cipro Price. Cipro Price. Cipro Price. What is Cipro. Is Cipro safe. My Cipro experience.